NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Health Business Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Business Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Affygility Solutions



Affygility Solutions Releases Self-Assessment Tool to Ensure Safe Potent Compound Handling



May 15th, 2009

Based on industry expertise, PCSSAT™ allows life science companies the ability to self-evaluate their program, procedures, and operational practices against best-in-class criteria.

“Prior to the release of PCSSAT™, it was difficult for biotech, pharmaceutical companies, and contract manufacturers to evaluate their potent compound handling programs and practices in an efficient manner,” said Dean Calhoun, CIH, President and CEO of Affygility Solutions. “Now, through the use of PCSSAT™ and Affytrac™, EH&S professionals in the life science industry can evaluate their company’s potent compound safety program across all facilities and operations, without the need for costly...


Source: Health Business Week (2009-05-15)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login